Your session is about to expire
← Back to Search
Other
Hyperbaric oxygen therapy for Cerebral Disorders
Phase 1
Waitlist Available
Led By Paul G Harch, M.D.
Research Sponsored by Paul G. Harch, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Cerebral disorder of greater than one year's duration
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after completion of hyperbaric oxygen therapy
Awards & highlights
Study Summary
Hypothesis: That HBOT can be toxic in the low-pressure range.
Eligible Conditions
- Cerebral Disorders
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after completion of hyperbaric oxygen therapy
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after completion of hyperbaric oxygen therapy
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Oxygen toxicity
Trial Design
1Treatment groups
Experimental Treatment
Group I: Hyperbaric oxygen therapyExperimental Treatment1 Intervention
Patients undergoing low pressure HBOT for chronic brain injury
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric oxygen therapy
2013
Completed Phase 3
~1580
Find a Location
Who is running the clinical trial?
Paul G. Harch, M.D.Lead Sponsor
4 Previous Clinical Trials
160 Total Patients Enrolled
Harch Hyperbaric Research FoundationOTHER
3 Previous Clinical Trials
130 Total Patients Enrolled
Paul G Harch, M.D.Principal InvestigatorLSU School of Medicine
4 Previous Clinical Trials
160 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger